Mumbai, India and Morristown, NJ—OmniActive Health Technologies has announced outcomes of a new study on the company’s branded red chili pepper extract Capsimax, showing significant increases in resting energy expenditure (REE) post-consumption. REE is the amount of energy expended by a person at rest in order to maintain the basic and vital functions of the body. REE accounts for 60-70% of total energy expenditure; increases in energy expenditure, such as that caused by exercise, have been linked to reduction in body weight.
The placebo-controlled, crossover trial was published in Journal of Obesity and Therapeutics. It included 24 healthy adults. The primary objective was to investigate the effect of Capsimax on REE; the researchers also documented body temperature and cardiovascular markers in order to assess safety.
The findings: Capsimax ingestion significantly increased change in REE as compared to placebo at 1, 2, and 3 hours post-dose. The change was even greater in overweight subjects at 1 and 2 hours. There were no adverse events or safety issues, but subjects did report an increased feeling of warmth.
Deshanie Rai, Ph.D., VP Global Scientific & Regulatory Affairs at OmniActive, commented in a press release: “These findings are consistent with our earlier published clinical results demonstrating a benefit of Capsimax on increased metabolic rate and adds another layer of substantiation that should help consumers feel confident that Capsimax is effective either with or without a meal.”